Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network (STOP-VTE)

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This study evaluates the use of extended venous thromboembolism prophylaxis (ePPx) following abdominopelvic cancer surgery within the NCI Community Oncology Research Program (NCORP) network, targeting surgeons and surgical advanced practice providers (APPs).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• SURGEON ELIGIBILITY CRITERIA FOR OPEN STEP 0 ENROLLMENT:

• \* Any surgeon performing gastrointestinal, genitourinary, or gynecologic cancer surgery within an NCORP site, including general surgeons, surgical specialists, urologists, and gynecologists. Surgeons do not need to be involved in research or have a Cancer Therapy Evaluation Program Identification (CTEP ID) to participate in this study

• SURGICAL APP ELIGIBILITY CRITERIA FOR OPEN STEP 0 ENROLLMENT:

• \* APPs providing postoperative care to patients operated by surgeons performing gastrointestinal, genitourinary, or gynecologic cancer surgery within an NCORP site, including general surgeons, surgical specialists, urologists, and gynecologists. Surgical APPs do not need to be involved in research or have a CTEP ID to participate in this study

• SURGEON ELIGIBILITY CRITERIA FOR OPEN STEP 1 ENROLLMENT:

• \* Must have completed the STOP-VTE Survey - Surgeon electronically (preferred) or on paper and have it transferred to Research Electronic Data Capture (REDCap) by the contact person(s)

• SURGICAL APP ELIGIBILITY CRITERIA FOR OPEN STEP 1 ENROLLMENT:

• \* Must have completed the STOP-VTE Survey - APP electronically (preferred) or on paper and have it transferred to REDCap by the contact person(s)

• SITE ELIGIBILITY PART 1-SITE ENROLLMENT IN OPEN:

• \* Have at least one eligible surgeon or surgical APP who completed the STOP-VTE Survey - Surgeon/APP

Locations
United States
North Carolina
Wake Forest NCORP Research Base
RECRUITING
Winston-salem
Contact Information
Primary
Karen Craver
NCORP@wfusm.edu
336-716-0891
Time Frame
Start Date: 2025-12-02
Estimated Completion Date: 2027-06-01
Participants
Target number of participants: 500
Treatments
Observational Part 1
Surgeons and APPs complete a survey on study. After completion of surgeon or APP survey, site contact person or CCDR lead complete site surveys on study.
Observational Part 2
Subset of surgeons and APPs from Part 1 complete a semi-structured interview on study.
Observational Part 3
Site contact person or CCDR lead complete a survey to identify a EHR Report Specialist on study. EHR Report Specialist performs an EHR Data Extraction and provides feedback on the process in a survey.
Related Therapeutic Areas
Sponsors
Leads: Wake Forest University Health Sciences
Collaborators: National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov